Altria Group (MO) Earnings Date & Reports

Key Takeaways

• Altria Group reported third-quarter net revenues of $6.13 billion, up 1.0% year over year, while revenues net of excise taxes rose 3.6% to $5.44 billion.
• Adjusted diluted earnings per share (EPS) came in at $1.52, up 4.8% from the prior year and a penny above the analyst consensus of $1.51.
• Reported (GAAP) diluted EPS climbed 7.1% to $1.51, supported by higher pricing across the smokeable products segment.
• Management raised full-year 2026 adjusted diluted EPS guidance to a range of $5.66 to $5.74, up from its prior outlook.
• The Board authorized a $1 billion expansion of the share repurchase program, underscoring a continued focus on shareholder returns.
• Get more details on the company's Major News, Today's Price Move, Price Targets, and Forecast on dedicated analysis pages.
• Explore Trending AI Robots to see AI-powered trading strategies currently in the spotlight.

Earnings Context and Why It Matters

Altria Group's quarterly earnings carry outsized weight for investors because the company operates in a structurally declining cigarette market, where pricing power and cost discipline must offset falling shipment volumes. The third-quarter report matters as a test of whether Marlboro and its discount brands can keep growing profits even as fewer consumers smoke. It also sheds light on Altria's strategic pivot toward smoke-free products, particularly the on! nicotine pouch brand. With the company raising guidance and expanding buybacks, this release offers a fresh signal on management's confidence in both near-term profitability and long-term shareholder returns.

Reported Results

For the third quarter ended September 30, 2026, Altria Group reported net revenues of $6.13 billion, a 1.0% increase from the prior-year quarter, while revenues net of excise taxes rose 3.6% to $5.44 billion. Reported diluted EPS increased 7.1% to $1.51, and adjusted diluted EPS grew 4.8% to $1.52, slightly ahead of the consensus estimate of $1.51.

Adjusted operating companies income (OCI), a key measure of segment profitability, increased 3.9% to roughly $3.1 billion. The smokeable products segment saw net revenues rise 0.8%, driven by higher pricing that partially offset lower shipment volume and a shift toward discount brands. Oral tobacco products net revenues declined 0.1%, pressured by lower shipment volume and higher promotional investments. On the growth side, on! shipment volume climbed 13.3% to 47.8 million cans, while Marlboro held a 39.5% retail share of the total cigarette category.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is designed to help identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking names like Altria and its peers, the AI Screener offers a practical way to surface actionable opportunities across the broader market.

Market Reaction and Investor Sentiment

Altria's third-quarter results were largely viewed as solid, with adjusted EPS edging past estimates and full-year guidance raised to $5.66–$5.74, a range that implies roughly 4.5% to 6.0% growth from the 2025 base of $5.42. Investors responded favorably to the combination of an earnings beat, improved outlook, and the $1 billion expansion of the buyback program, which reinforces the company's cash-return story. Sentiment remains balanced, however, as the market weighs ongoing cigarette volume declines, a competitive nicotine pouch category, and an evolving regulatory environment against Altria's dependable pricing power and dividend track record.

Forward Outlook and Key Factors to Monitor

Following the guidance raise, investors will be watching whether Altria can sustain its pricing-driven profit growth in the smokeable segment. Cigarette shipment volume fell an estimated 4% when adjusted for trade inventory movements, reflecting a broader industry decline. How effectively higher pricing offsets that volume pressure will remain central to the earnings narrative.

Another area to monitor is the oral tobacco and nicotine pouch business. The on! brand delivered double-digit shipment growth, but competitive investment across the category remains elevated. Progress on on! PLUS flavor extensions and retail positioning will be important for maintaining momentum.

Finally, regulatory developments and capital allocation deserve close attention. Altria and its subsidiaries have pursued legal action seeking a more predictable FDA authorization process, and any shift in the regulatory landscape could influence the pace of the smoke-free transition. With dividends and share repurchases now central to the story, investors will also look for continued clarity on how the company balances reinvestment against returning cash to shareholders.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations